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Historically, our understanding of molecular genetic aspects of human germ cell development has been lim-
ited, at least in part due to inaccessibility of early stages of human development to experimentation. However,
the derivation of pluripotent stem cells may provide the necessary human genetic system to study germ cell
development. In this study, we compared the potential of human induced pluripotent stem cells (iPSCs),
derived from adult and fetal somatic cells to form primordial and meiotic germ cells, relative to human
embryonic stem cells. We found that ∼5% of human iPSCs differentiated to primordial germ cells (PGCs) fol-
lowing induction with bone morphogenetic proteins. Furthermore, we observed that PGCs expressed green
ﬂuorescent protein from a germ cell-speciﬁc reporter and were enriched for the expression of endogenous
germ cell-speciﬁc proteins and mRNAs. In response to the overexpression of intrinsic regulators, we also
observed that iPSCs formed meiotic cells with extensive synaptonemal complexes and post-meiotic haploid
cells with a similar pattern of ACROSIN staining as observed in human spermatids. These results indicate that
human iPSCs derived from reprogramming of adult somatic cells can form germline cells. This system may
provide a useful model for molecular genetic studies of human germline formation and pathology and a novel
platform for clinical studies and potential therapeutical applications.
INTRODUCTION
Mammalian somatic cells can be reprogrammed to induced
pluripotent stem cells (iPSCs) via the introduction of a small
set of transcription factors that encode OCT3/4, SOX2 and
KLF4 with or without addition of c-MYC, or an alternate com-
bination of OCT3/4, SOX2, LIN28 and NANOG (1–9).
Regardless of the gene combination, however, human iPSC
lines bear remarkable similarity to human embryonic stem
cells (hESCs) in terms of their morphology, culture and
proliferation, gene expression and ability to differentiate to
mesoderm, endoderm and ectoderm both in vitro and in vivo
in teratoma assays (10,11). A hallmark of pluripotency in vivo
and in vitro, however, is the ability to differentiate to the
germ cell lineage (12–17). Recently, human iPSCs derived
from reprogramming of fetal somatic cells have been shown
to differentiate to early-stage primordial germ cells (PGCs),
further indicating their similarity in potential to hESCs (4).
However, the ability of iPSCs derived from reprogramming of
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nor has the ability of iPSCs (from fetal or adult sources) to
differentiate to mature meiotic and post-meiotic germ cells.
Human ESCs can spontaneously differentiate to PGCs, albeit
at a low frequency, when factors that promote self-renewal,
such as feeder cells and basic ﬁbroblast growth factor, are
removed (13,18). The efﬁciency of spontaneous differentiation
to PGCs can be increased with the addition of bone morphogen-
etic proteins (BMP-4, -7 and -8b), use of prolonged culture and
co-culture with human or mouse fetal gonad stromal cells
(4,12,15,16,19). PGC differentiation has been diagnosed in
complex stem cell cultures primarily by the analysis of germ
cell-speciﬁc gene and protein expression, and more recently
by the use of reporter constructs with the expression of green
ﬂuorescent protein (GFP) under control of the germ cell-speciﬁc
VASA or OCT4 promoters (15,20,21).
Differentiation of germ cells that progress through meiosis to
form functional gametes is still a challenge with in vitro differen-
tiation of germ cells, in both the human and the mouse models.
Meiotic prophase I encompasses the formation of the synaptone-
mal complex (SC), the pairing of homologous chromosomes
(synapsis) and reciprocal recombination at the sites of crossing
over between homologs (22). The different stages of meiosis
can be analyzed by the immunoﬂuorescence analysis of SC pro-
teins (SCPs) and by FACS (fluorescent-activated cell sorting)
analysis to examine the formation of haploid cells. Recently,
Kee et al.( 15) differentiated hESCs to germ cells that had
initiated meiosis and progress e dt of o r mh a p l o i dg e r mc e l l s .
These authors observed that overexpression of members of the
DAZ (Deleted in AZoospermia) gene family, DAZ, DAZL
(Deleted in AZoospermia-Like)a n dBOULE, promoted the pro-
gression of nascent PGCs to initiate meiosis and produce the
haploid cells unique to germ cell development (15).
Although hESCs have been shown to differentiate to male
and female meiotic cells, the ability of iPSCs to progress
through meiosis has not been examined. Here, we compared
the ability of two iPSC and two hESC lines to differentiate
to PGCs and form meiotic and post-meiotic cells. To
analyze the potential of iPSCs overall, two independently
derived iPSC lines were chosen for analysis; iHUF4 with a
normal 46:XY karyotype, derived in our laboratory using
adult ﬁbroblasts and OCT3/4, SOX2, KLF4 and c-MYC repro-
gramming factors (B. Byers et al., submitted for publication),
and iPS(IMR90) with a normal 46:XX karyotype available
from the National Stem Cell Bank, derived using fetal ﬁbro-
blasts and OCT3/4, SOX2, NANOG and LIN28 reprogramming
factors (2). In addition, two commonly used hESC lines that are
available from the National Stem Cell Bank were chosen for
comparison: H9 (karyotype 46:XX) and HSF1 (karyotype
46:XY). Lines were chosen based on their availability,
karyotype and similarity of growth conditions to hESCs.
RESULTS
BMP-induced differentiation of iPSCs
To examine whether the addition of BMPs can induce germ
cell differentiation from iPSCs, as described for hESCs, we
differentiated iHUF4 and iPS(IMR90) cells for 7 and 14
days with and without the addition of BMP-4, -7 and -8b as
previously described for hESCs (15,16). We observed that
BMP-induced cultures had an increased expression of the
germ cell-speciﬁc marker, VASA, as shown by western blot-
ting (Supplementary Material, Fig. S1). We then differentiated
all cell lines in parallel, iHUF4, iPS(IMR90), H9 and HSF1 for
7 and 14 days via the feeder-free adherent culture with BMP
supplementation. We observed that all cell lines maintained
a similar hESC-like colony morphology during routine
culture and acquired morphologies distinct from undifferen-
tiated cells after 14 days of differentiation (Fig. 1A). More-
over, we observed an increased expression of the germ
cell-speciﬁc proteins, VASA and DAZL, with differentiation;
the level of expression of these proteins was similar at the
day 7 and 14 time points between all cell lines (Fig. 1B).
Notably, we also detected a low level of VASA and DAZL
protein expression in undifferentiated iHUF4 cells, and
VASA expression in one sample of undifferentiated
iPS(IMR90) cells (Fig. 1B), likely indicating the presence of
a subpopulation of cells expressing germ cell markers even
in the undifferentiated culture. The expression and localization
of the VASA protein was also detected by immunostaining for
all cell lines, in differentiated cells and also in occasional cells
in undifferentiated cultures (data shown for iPSCs, Fig. 1C).
Gene expression analysis
To further assess the differentiation of iPSCs to different
lineages, we assayed gene expression after 0, 7 and 14 days
of differentiation by quantitative RT–PCR for the pluripotency
factors OCT3/4 and NANOG, for the trophectodermal (keratin
7, KRT7), endodermal (GATA-binding protein 6, GATA6),
mesodermal (Actin, alpha cardiac muscle 1, ACTC) and ecto-
dermal (neural cell adhesion molecule 1, NCAM1) markers
and for the germ cell markers, IFITM1 (interferon induced
transmembrane protein 1), PELOTA (PELOTA homolog) and
PRDM1A (PR-DoMain containing 1A).
The combined expression of endogenous and exogenous
pluripotency markers [the later derived from viral vectors con-
taining NANOG and OCT3/4 for iPS(IMR90) and OCT3/4 for
iHUF4] was signiﬁcantly higher in undifferentiated iPSCs rela-
tive to hESCs, but then decreased to the similar levels with
differentiation for day 14 (Fig. 2). Upon differentiation, all
cell lines expressed markers of endoderm, mesoderm and ecto-
derm, as well as trophectoderm, indicating a similar differen-
tiation potential between iPSCs and hESCs. Some differences
were observed, however; for example, undifferentiated iPSCs
had signiﬁcantly higher expression of ACTC relative to
hESCs and the expression of GATA6 was signiﬁcantly higher
in undifferentiated iPS(IMR90) relative to other cell lines.
When we examined the mRNA expression of germ cell
markers, we observed an increased expression with differen-
tiation for all cell lines with variable but the similar levels
of expression between iPSCs and hESCs (Fig. 2). In undiffer-
entiated cells, iPS(IMR90) had signiﬁcantly higher expression
of IFITM1 relative to other cell lines and both iPSC lines had
signiﬁcantly higher expression of PELOTA relative to hESCs.
However, the expression of PRDM1A was signiﬁcantly lower
in undifferentiated iHUF4 cells relative to other cell lines. We
also note that at the RNA level, the expression of VASA is
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lines as has been observed previously (13–16).
Analysis of VASA:GFP-transduced cells
To compare the efﬁciency of germ cell differentiation between
iPSCs and hESCs, we next transduced each of the pluripotent
stem cell lines with a VASA:GFP reporter system and used
FACS to determine the percentage of PGCs differentiated, as
described previously (15). Lines transduced with the
VASA:GFP reporter were designated as follows: vH9,
vHSF1, viPS(IMR90) and viHUF4. We observed that the per-
centage of GFP-positive cells after 7 days of differentiation
was very similar between vH9 and vHSF1 cell lines (2.28
and 2.39%, respectively) and comparable with previous
reports (Fig. 3A and B). In contrast, we observed that the per-
centage of GFP-positive cells was more than two times higher
in differentiated cultures of viPS(IMR90) and viHUF4 cell
lines (4.85 and 5.27%, respectively) relative to hESCs,
whereas the baseline percentages of VASA:GFP-positive
cells in undifferentiated cultures were similar and very low
for all cell lines (vH9 0.64%, vHSF1 0.75%, viPS(IMR90)
0.49%, viHUF4 0.78%; Fig. 3B).
Although western analysis suggested a similar expression of
VASA between all cell lines after 7 days of differentiation, the
percentage of VASA:GFP-positive cells was higher for iPSCs
relative to hESCs suggesting that although the expression level
of VASA was similar, the number of germ cells may be
different. The western results also indicated a higher
expression of VASA for undifferentiated iHUF4 cells;
however, no difference was detected in the numbers of
VASA:GFP-positive cells by FACS. In general, FACS analy-
sis is likely to be more sensitive than western blotting;
however, it is also possible that cells express substantially
different amounts of VASA protein at different stages of
development, and thus numbers may vary as protein levels
remain similar.
Following sorting, VASA:GFP-transduced cells were ana-
lyzed by immunostaining for the VASA protein and by quan-
titative RT–PCR for germ cell markers, pluripotency markers
and other lineage markers. We observed that sorted
GFP-positive cells were positive for VASA by immunostain-
ing and that no VASA immunopositive cells were detected
in the GFP-negative population (Fig. 3C). We also detected
very low levels of VASA expression by qPCR in both the
VASA-positive and the VASA-negative populations,
suggesting a differential expression of mRNA and protein
for VASA (data not shown). GFP-positive iPSCs had signiﬁ-
cantly higher expression of germ cell markers than
GFP-negative cells including GCNF (germ cell nuclear
factor), IFITM1, STELLAR (STELLA-related) and
PELOTA; in viHUF4 iPSCs, we also observed signiﬁcantly
higher expression of the meiotic protein DMC1 (distribution
of meiotic control 1) and PRDM1A genes (Fig. 3D). The plur-
ipotency markers OCT3/4 and NANOG were also expressed in
germ cells with the expression of OCT4 at signiﬁcantly higher
Figure 1. Human ESCs (H9 and HSF1) and iPSCs [iPS(IMR90) and iHUF4] were differentiated as adherent cultures with 20% fetal bovine serum medium sup-
plemented with BMP-4, -7, and -8b. (A) Morphology of undifferentiated and differentiated cells; after 14 days of differentiation, cultures appeared conﬂuent, with
cell morphology distinct from undifferentiated cells for all cell lines. (B) Western blot analysis of germ cell-speciﬁc proteins VASA and DAZL in undifferentiated
cells and cells differentiated for 7 and 14 days. Increased expression of both VASA and DAZL was observed for all cell lines with differentiation, with the level of
expression being similar at day 7 and day 14 time points between all the cell lines. Notably, a low level of VASA and DAZL protein expression was detected for
undifferentiated iHUF4 cells and VASA expression in one sample of undifferentiated iPS(IMR90) cells. GAPDH is shown as a loading control and 293T cells are
used as a negative control. Two independent samples are shown for each time point for all cell lines. (C) The expression and cytoplasmic localization of the
VASA protein was also detected by immunostaining for all cell lines after differentiation. In addition, occasional cells in undifferentiated cultures were
stained positive for all cell lines. Representative images are shown for iHUF4 and iPS(IMR90) cells; green VASA, blue DAPI, merged image and lower mag-
niﬁcation image showing the surrounding cells. Scale bars: 200 mm (A); 50 mm (C).
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in both cell lines, as well, but primarily in the GFP-negative
population suggesting that the negative population maintained
undifferentiated pluripotent stem cells or cells of other early
lineages that still maintained NANOG at low levels. All
other lineage markers analyzed were enriched only in the
GFP-negative populations.
SC formation by overexpression of DAZL, BOULE
and DAZ
We next tested whether iPSCs possess the ability to initiate
and progress through meiosis. For this purpose, we followed
previously published protocols to induce meiosis by
overexpression of genes of the DAZ gene family and then
examined the number and developmental stage of differen-
tiated meiotic cells formed as reported previously (15,23,24).
Cells were collected at different time points, up to 14 days
after transduction and co-immunostained for SCP3, a com-
ponent of the SC in meiotic prophase I, and CENtromeric
Protein A (CENP-A), a component of the centromere. We
observed that the majority of the cells did not have detectable
SCP3 staining, indicating that the cells either had not entered
meiosis or had already completed meiosis. However, a subset
of cells in all the pluripotent stem cell lines had punctate SCP3
staining, indicating that the cells had likely entered leptotene at
meiotic prophase I, or elongated SCP3 staining, a pattern cor-
responding most closely to the zygotene, pachytene or
Figure 2. Gene expression analysis for undifferentiated cells and cells differentiated with BMPs for 7 and 14 days. The combined expression of endogenous and
exogenous (derived from viral vectors) pluripotency markers OCT3/4 and NANOG was signiﬁcantly different between all undifferentiated cell lines; iPSCs had
higher expression relative to hESCs. At day 7 of differentiation, iPS(IMR90) and HSF1 had higher expression of OCT3/4 and iPS(IMR90) had higher expression
of NANOG compared with other cell lines; however, at day 14, the levels decreased to the similar levels between all cell lines. As a further indication of differ-
entiation, the expression of KRT7 (trophectodermal marker), GATA6 (endodermal marker), ACTC (mesodermal marker) and NCAM1 (ectodermal marker)
increased similarly for all cell lines upon differentiation, although at day 7 the expression of GATA6 was signiﬁcantly higher in HSF1 cells relative to
iPS(IMR90) cells and at day 14 the expression of KRT7 and NCAM1 was higher in iHUF4 cells relative to H9 or HSF1 cells, respectively. In undifferentiated
cells, iPS(IMR90) had signiﬁcantly higher expression of KRT7 relative to H9 and iHUF4, and GATA6 relative to all other cell lines. The expression of ACTC
was signiﬁcantly higher in both undifferentiated iPSCs relative to hESCs, but the expression of NCAM1 was higher in H9 cells relative to HSF1 and iPS(IMR90)
and in iHUF4 cells relative to HSF1 cells. The expression of early germ cell markers IFITM1, PELOTA and PRDM1A indicate the potential of all cell lines to
differentiate toward the germ cell lineage, with similar expression levels between hESCs and iPSCs. However, the expression of IFITM1 at day 7 and PELOTA in
undifferentiated cells was signiﬁcantly higher in iPSCs relative to hESCs. In addition, the expression of IFITM1 in undifferentiated iPS(IMR90) cells was sig-
niﬁcantly higher relative to other cell lines, and in HSF1 relative to H9 and iHUF4 cells. The expression on PRDM1A was signiﬁcantly higher at day 7 in HSF1
cells relative to H9 and iPS(IMR90) cells. Values are normalized to expression levels of two housekeeping genes, GAPDH and RPLPO, and results are showna s
fold difference relative to undifferentiated H9 cells using the log scale. Statistical testing was performed comparing the values of different cell lines within a time
group; undiff, day 7, and 14, for each gene separately. Error bars indicate SD between three technical replicates. ∗P , 0.05, one-way ANOVA.
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overlapped with CENP-A and DAPI staining, indicating colo-
calization to meiotic chromosomes. After overexpression of
the DAZ family genes, all lines had cells that were character-
ized by both punctate and elongated SCP3 staining; we termed
cells that were transduced to overexpress DAZ family genes as
follows: diPS(IMR90), diHUF4, dH9 and dHSF1. We
observed that the diPS(IMR90) cell line had a similar percen-
tage of punctate SCP3 staining relative to both dH9 and
dHSF1 cell lines (7.13, 9.36 and 7.88%, respectively) and a
similar percentage of elongated staining pattern relative to
dHSF1 cells (4.63 and 4.13%, respectively; Fig. 4B). The
diHUF4 cells also had a greater percentage of cells with punc-
tate staining (20.86%) compared with all other cell lines, but a
Figure 3. Human iPSCs and ESCs were transduced with a lentiviral vector with VASA promoter driving eGFP expression. Cells were differentiated for 7 days
with BMPs, and the GFP-positive cells were analyzed and sorted by ﬂow cytometry. (A) FACS analysis of cells after 7 days of differentiation. Gating for cell
sorting was setup using eGFP and PE parameters; eGFP-positive and PE-negative cells were collected for further analysis, excluding the double-positive auto-
ﬂuorescence cells that are located on the diagonal axis. (B) The percentage of GFP-positive cells for transduced undifferentiated cells and after 7 days of differ-
entiation. The percentage of GFP-positive cells was ≤1% for all undifferentiated cell lines; however, after 7 days of differentiation, hESCs had ≥2% positive
cells and iPSCs had  5% GFP-positive cells. (C) Immunostaining for the VASA protein in sorted GFP-positive and GFP-negative cells. All GFP-positive cells
were positive for VASA staining, whereas no VASA-positive cells were found from the GFP-negative cell population. Representative images are shown for
differentiated viPS(IMR90) and viHUF4 cells. (D) Gene expression analysis for GFP-positive and GFP-negative differentiated viPS(IMR90) and viHUF4
cells. The expression of germ cell markers DMC1, GCNF, IFITM1, PRDM1A, STELLAR and PELOTA was signiﬁcantly higher in GFP-positive cell population
compared with GFP-negative population, except for viPS(IMR90) for DMC1 and PRDM1A. In addition, the expression of OCT3/4 was signiﬁcantly higher in
GFP-positive population for viHUF4 cells. The expression of NANOG, GATA6, ACTC, NCAM1 and KRT7 was only detected in GFP-negative populations.
Values are normalized to the expression levels of two housekeeping genes, GAPDH and RPLPO, and results are shown as fold difference relative to
GFP-negative H9 cells. Error bars indicate SD between three technical replicates. ∗P , 0.05, unpaired t-test. Scale bar 50 mm (C).
756 Human Molecular Genetics, 2011, Vol. 20, No. 4similar percentage of elongated staining relative to dH9 cells
(1.23 and 0.75%, respectively).
We further focused on SCP3 staining in undifferentiated
cells and cells differentiated with BMPs for up to 14 days,
in the absence of overexpression of the members of the DAZ
gene family. We were surprised to observe a relatively high
percentage of punctate staining for all pluripotent stem cell
lines, including undifferentiated HSF1 and iHUF4 cells (19.5
and 23.38%) and remarkably a rare cell with elongated
SCP3 staining in both iPS(IMR90) and iHUF4 undifferentiated
cultures (Fig. 4B and C, Supplementary Material, Fig. S2). To
examine whether the high percentage of SCP3 staining in these
undifferentiated cultures resulted from the presence of cells
that had spontaneously differentiated, we manually segregated
colonies into those that were morphologically most similar to
undifferentiated hESCs and those that were more likely to
contain differentiated cells especially along the perimeters.
We then observed a substantial decrease in punctate staining
patterns with punctate staining reduced to 2.5% of H9 cells,
5% of HSF1 cells, 1.5% of iPS(IMR90) cells and 3% of
iHUF4 cells; moreover, no elongated staining was detected.
When we examined whether the differentiation of meiotic
cells can be induced with only BMPs, without transduction
of DAZ gene family members, we observed that the percentage
Figure 4. Meiotic progression of iPSCs and hESCs. Meiotic spreads were prepared from undifferentiated cells, cells differentiated with supplementation of BMPs
up to 14 days and cells with exogenous overexpression of human DAZ gene family members and then differentiated with BMPs up to 14 days. The meiotic
spreads were analyzed by immunostaining against SCP3 (red), CENP-A (green) and DAPI (blue). (A) Meiotic spreads were classiﬁed as punctate or elongated
SCP3 staining patterns, corresponding to the early leptotene stage (punctate) and the later zygotene, pachytene and diplotene stages (elongated) of meiotic pro-
phase I. Representative images are shown for both groups. (B) Meiotic spreads from dH9, dHSF1, diPS(IMR90) and diHUF4 cell lines were classiﬁed as punctate
or elongated SCP3 staining patterns and quantiﬁed by counting 800 cells from differentiated samples and 200 cells from undifferentiated samples. With over-
expression, punctate and elongated SCP3 staining was detected in all cell lines; diPS(IMR90) cell line had both punctate and elongated staining percentages
similar to dHSF1, diHUF4 cell line had a similar percentage of elongated staining percentage to dH9 cells, but a high percentage of punctate staining compared
with all cell lines. Differentiated cells without overexpression had no elongated staining in any of the cell lines. However, rare cells with elongated staining were
detected for both iPSC lines in undifferentiated cell cultures (W). When only morphologically good colonies were manually picked from undifferentiated cultures
(G), no elongated staining was seen and the percentage of punctate staining decreased compared with whole culture (W). (C) Representative images are shown for
undifferentiated and overexpressed cells. Some cells with punctate staining were observed for the undifferentiated H9 and HSF1 cells, for iPS(IMR90) and iHUF4
cell lines elongated SCP3 staining was also detected. Elongated staining was observed for all cell lines after overexpression. Scale bar 10 mm (A and C).
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pared with undifferentiated whole cultures as in H9 (6.3%),
remained similar as in HSF1 (18%) and iPS(IMR90) (4.8%)
or decreased as in iHUF4 (10.4%). Notably; however, there
was no elongated staining detected for any of the cell lines
with BMP induction alone. Together, these results indicate
that although the overall morphology of undifferentiated cul-
tures of pluripotent stem cells (both hESCs and iPSCs) may
appear indicative of the undifferentiated state, some cells
most likely can transit to a germline fate. Moreover, the
addition of BMPs does not substantially increase the number
of meiotic cells, whereas exogenous gene expression could
promote both initiation and progression from punctate to
elongated complex formation. Finally, we observed that both
iPSC lines had cells with rare elongated staining in undifferen-
tiated cells, in contrast to hESCs where elongated structures
were never observed.
The observed elongated SCP3 staining was similar to pre-
viously published staining for hESCs and clinical samples of
developing human oocytes (15,25). The nuclei of dH9,
dHSF1 and diPS(IMR90) cells had multiple SCP3-positive
strings of different length and thickness; however, the nuclei
of diHUF4 cells had a different staining pattern, with fewer
and thicker SPC3-positive complexes (Fig. 4C). This, together
with the relatively low percentage of elongated staining and
high punctate staining in diHUF4 cells, may indicate that
these cells might be arrested at early stages of meiotic
prophase I.
Haploid cell population analysis
To determine if the overexpression of DAZ gene family
members in iPSCs can promote completion of meiosis and
generation of haploid cells, FACS was used to isolate
haploid cells by DNA content analysis, after transduction
and 14 days of differentiation. FACS parameters of haploid
cells (1N) were set by using human semen sample procured
from an IVF clinic as a control (Fig. 5A). We observed that
a small percentage of cells had 1N DNA content in a similar
level between all cell lines [diPS(IMR90) 1.6%, diHUF4
1.66%, dH9 1.5% and dHSF1 1.96%]. A similar percentage
of cells (1.34%) was also observed for non-transduced HSF1
cells in the 1N gating parameter. Although there was no
clear peak detected by FACS, the 1N DNA content cells
were sorted and further analyzed with the same gating
parameter being used for pluripotent stem cells as the
control sperm sample.
We examined the DNA content of 1N sorted population by
FISH staining using a probe against chromosome 16 (Fig. 5B).
Cells with a single copy of chromosome 16 were detected for
all cell lines in the sorted putative 1N population [dH9 19%,
dHSF1 21%, diPS(IMR90) 14%, diHUF4 13%; Fig. 5B and
C]. Because of the low efﬁciency of haploid cell generation,
it was not possible to design gating capable of retrieving a
pure population of 1N cells; instead the 1N population was
enriched but also contained 2N cells and debris. For isolated
non-transduced HSF1 cells, no cells with single chromosome
16 were observed, conﬁrming that meiosis was induced by
overexpression of DAZ genes in iPSCs as in hESCs (15).
We further analyzed the same populations of 1N cells by
ACROSIN staining, a marker of the acrosome in spermatids.
We observed distinct perinuclear localization of ACROSIN
in the 1N population for all cell lines, including the karyotypi-
cally XX lines dH9 and diPS(IMR90) (Fig. 5D). It has been
previously shown that human germ cells differentiated in
vitro express both male and female genetic programs regard-
less of their karyotype (13). We observed that 35–72% of
cells in the 1N sorted population were positive for
ACROSIN (Fig. 5E), which was higher than the percentage
of haploid cells in the population, suggesting that ACROSIN
may be expressed broadly in meiotic cells before haploidy.
This is further indicated by the ACROSIN-positive cells
observed in the non-transduced HSF1 cells, where no
haploid cells were detected. However, the percentage of
positive cells for the non-transduced HSF1 cells was lower
compared with the transduced dHSF1 cells (31 and 72%,
respectively), further indicating the induction of meiosis by
overexpression of DAZ genes. Further studies of the ultrastruc-
ture of the ACROSIN-positive cells via electron microscopy
will aid in diagnosing the functionality of the cells.
DISCUSSION
Human germ cell development is poorly understood with most
of our knowledge derived by extrapolation of studies in mice.
Nonetheless, although human germ cell development undoubt-
edly shares similarity to that of the mouse given their
similarities in embryology, it is also clear that genetic require-
ments for human germ cell development are unique. This is
illustrated by a number of observations. First, there are
several Y chromosome genes, including the DAZ genes, that
are absent in mice (26–29). Thus, understanding their role
and that of related homologs, such as DAZL and BOL whose
functions appear to overlap at least minimally, is difﬁcult (or
impossible) on a genetic background that lacks key regulators.
Second, similarly in the case of X chromosome, women
require two X chromosomes for oocyte development,
whereas mice are fertile with just a single X (30–32). Third,
it has been observed that reproductive genes and proteins
may evolve rapidly (33,34). Indeed, the human genes,
STELLAR, GDF3 and NANOG, encode examples of extremely
divergent proteins that are expressed in germ cells. Mouse and
human Stella homologs are just 30% identical at the amino
acid level and have distinct differences in expression
(14,35). Fourth, it is clear that humans are remarkably infertile
compared with other species, with nearly half of the infertility
cases linked to faulty germ cell development (36). Finally,
humans are remarkably imprecise in carrying out some key
aspects of germ cell development that are reportedly the
most highly conserved. For example, meiotic chromosome
missegregation is rare in most model organisms. In the
common yeast, chromosome missegregation occurs in  1/
10 000 cells. In ﬂies, missegregation occurs in 1/1000 to 1/
2000 cells and in mice in ≤1/100. In humans, meiotic chromo-
some missegregation occurs in 5–20% or more of cells
depending on sex and age (37). Thus, there are fundamental
differences in the genetics, biology and pathology of human
germ cell development, compared with model organisms,
that merit studies of human germ cell development per se.
758 Human Molecular Genetics, 2011, Vol. 20, No. 4Yet, given the timeline of human germ cell development in
vivo in the ﬁrst trimester, it has not been possible to probe
gene function on a human genome background.
Recently, the differentiation of hESCs has been used to
probe gene function in human germ cell development (15).
In these studies, human germ cell development was assessed
following silencing and overexpressing of genes of the
DAZ gene family that encode germ cell-speciﬁc cytoplasmic
RNA-binding proteins (not transcription factors). Results indi-
cated that human germ cell formation and developmental pro-
gression could be modulated by the DAZ gene family with
human DAZL shown to function in PGC formation, whereas
the Y chromosome homolog, DAZ, and closely related autoso-
mal homology, BOULE, promoted later stages of meiosis and
development of haploid gametes. In spite of these successes,
however, further genetic analysis is clearly justiﬁed; the use
Figure 5. DNA content analysis for diPS(IMR90), diHUF4, dH9 and dHSF1 cells transduced with the DAZ gene family overexpression factors and differentiated
with BMPs for 14 days. (A) Human semen was used as a positive control to identify the location of haploid cells (1N) by ﬂow cytometer. A distinct peak of 1N
population was not detected for any of the cell lines, but around 1.5% of cells were collected using the gating based on the human semen sample. Cells from the
non-transduced HSF1 sample were also collected. (B) Fluorescent in situ hybridization for chromosome 16 in the sorted 1N cell population. Cells with one
chromosome 16 are shown for each cell line. HSF1 control cells with no transduction did not have cells haploid for chromosome 16. (C) Cells with one chromo-
some 16 were identiﬁed and counted from 1N sorted cell populations; 13–21% of transduced cells had one chromosome 16. (D) A similar ACROSIN staining
pattern seen in human spermatids was observed in some of the 1N sorted cells for all cell lines. Some positive cells were also observed in the non-transduced
HSF1 cells. Undifferentiated H9 cells are shown as a negative control with low background staining. (E) Cells with ACROSIN-positive staining were identiﬁed
and counted for 1N sorted cell samples. The percentage of positive cells varied between 35 and 72%. Scale bar 5 mm (B), 5 mm (and 40 mm for H9 undiff) (D).
Human Molecular Genetics, 2011, Vol. 20, No. 4 759of iPSCs would allow us to take advantage of naturally occur-
ring human genetic variants, including complex deletions and
rearrangement, for further analysis.
In this study, we show that human adult and fetal somatic
cell-derived iPSC lines can differentiate to PGCs in a similar
manner to hESCs, with some differences noted. In addition,
we observed that like hESCs, germ cells differentiated from
iPSCs entered meiosis, a functional marker of germ cell for-
mation and differentiation, when DAZ family proteins were
overexpressed. Furthermore, data indicate that the iPSC lines
can differentiate to haploid cells with characteristic staining
of ACROSIN for spermatid. With these results, we suggest
that iPSCs may provide a useful platform for the study of
human germ cell development and infertility defects. Indeed,
our data indicate that germ cell differentiation may occur
more spontaneously in iPSCs than in hESCs. This may be
linked to the process of reprogramming, enhanced expression
of pluripotency markers or a preferential differentiation to
germline rather than somatic cell derivatives.
Finally, we note that although a major cause of infertility is
the production of few or no germ cells, often associated with
meiotic defects, today’s treatments for infertility are largely
ineffective for those with few or no germ cells (38,39). We
envision that the production of germ cells from iPSCs may
enable direct screening and assay not only of genetic factors
but also for chemicals or small molecules that promote germ
cell survival or demise. Ultimately, this may contribute to
new strategies for the diagnosis and treatment of infertility, a
common health problem that affects 10–15% of reproductive-
age couples.
MATERIALS AND METHODS
Cell culture
Human ESCs H9 and HSF1, human fetal-derived iPSC line
iPS(IMR90) and human adult-derived iPSC line iHUF4 (lenti-
viral transfection with OCT3/4, SOX2, KLF4 and c-MYC)
were used in the experiments. Human ES cells and iPS cells
were maintained on irradiated MEFs in KoDMEM culture
medium for ES cells and DMEM/F12 for iPS cells, sup-
plemented with 20% Knockout serum replacer, 2 mM
L-glutamine, 0.1 mM nonessential amino acids, 10 ng/ml of
basic FGF (all Invitrogen) and 0.1 mM 2-mercaptoethanol
(Millipore). Cells were passaged every 3–5 days using 1 mg/
ml of Collagenase IV (Invitrogen). The feeder-free culture
was maintained on matrigel-coated plates (BD Biosciences)
with culture medium conditioned on MEFs for 24 h. Cells
were differentiated on matrigel-coated plates with differen-
tiation medium; KoDMEM supplemented with 20% fetal
bovine serum (Hyclone Laboratories), 2 mML -glutamine,
0.1 mM non-essential amino acids, 0.1 mM 2-mercaptoethanol
and 50 ng/ml of BMP-4, -7 and -8b (R&D systems).
Western analysis
Adherent cell cultures were incubated with TrypLE (Invitro-
gen) for 10 min and collected by scraping. Cells were
washed twice with PBS and resuspended with RIPA buffer
(Sigma) plus 2× protease inhibitors (Complete Mini,
Roche). Sample tubes were rocked for 20 min and centrifuged
for 20 min at 16 000g at +48C. Supernatant was measured for
protein concentration and 35 mg was denatured at a 1:1 ratio
with 2× Laemmli buffer at 958C for 5 min, then loaded
onto 10% SDS–PAGE gel. The gels were run at 150 V for
70 min (DAZL) or 85 min (VASA) and transferred to a
PVDF membrane for 1 h at 100 V in CAPS buffer (10 mM
CAPS, 10% methanol, pH 11). Transferred blots were
blocked in 5% non-fat milk for 1 h at room temperature. The
blot was incubated overnight at +48C with primary antibody
[1:500 for anti-VASA (Abcam or R&D Systems), 1:500
anti-DAZL-1 50 (prepared by the lab), 1:10 000 anti-GAPDH
(Abcam)], followed by two rinses and 3 × 5 min washes in
0.1% Tween-20 (Sigma-Aldrich) in PBS, pH 7.5. Secondary
antibody [1:10 000 anti-rabbit-HRP conjugated (Amersham)]
was incubated for 1 h followed by the same washes. ECL+
(Amersham) was used to detect the HRP signal on ﬁlm.
Immunostaining of ﬁxed cells
Cells were ﬁxed with 4% paraformaldehyde (USB corpor-
ation) for 15 min and washed 3 × 5 min with PBS (Invitro-
gen). Cells were then permeabilized with 0.3% Triton X-100
(Sigma-Aldrich) in PBS for 30 min and blocked with 4%
chicken serum (Sigma-Aldrich) in PBS for 30 min. Rabbit
polyclonal anti-VASA primary antibody (Abcam) was used
with 1:200 dilution and incubated overnight at +48C. Cells
were washed 3 × 5 min with 0.1% Tween-20 in PBS.
Chicken anti-rabbit Alexa 488 secondary antibody (Invitrogen)
was used with a dilution of 1:300 and incubated for 1 h at
room temperature. Cells were washed again as before and
1 ng of DAPI (Sigma Aldrich) was added to the cells.
VASA:GFP transduction and flow cytometry
Undifferentiated cells were transduced on matrigel with a len-
tiviral vector carrying GFP gene under the VASA promoter
(15) for 6 h at +378C. Conditioned medium was added 2:1
and cells were further incubated overnight. Virus supernatant
was washed off four times with PBS, and the selection was
started the following day with geneticin (Invitrogen) for 7
days. Cells were passaged to MEFs and then moved back to
matrigel followed by differentiation with BMPs. Cell cultures
were incubated with 1 mg/ml of Collagenese IV for 10 min
and with TrypLE (Invitrogen) for 10 min and collected by
scraping. Cells were washed three times by medium exchange
and centrifugation. Single cell suspension was obtained ﬁlter-
ing cell solution through a 40-mm cell strainer (BD).
Gene expression analysis
Total RNA was prepared as described in the RNeasy Mini Kit
(Qiagen) with on-column DNase I digestion. About 1 mgo f
total RNA from each sample was used for random primed
reverse transcription, which was carried out as described in
the product protocol (SuperScriptTM III First-Strand Synthesis
System for RT-PCR, Invitrogen), and 1.25 ml of the cDNA
was preampliﬁed using 96 different 0.2× Taqman assays
(Applied Biosystems, Carlsbad, CA, USA) as primers in a reac-
tion; 5 ml2 × buffer (from CellsDirectTM One-Step qRT-PCR
760 Human Molecular Genetics, 2011, Vol. 20, No. 4kit, Invitrogen), 2.5 ml Taqman assay mix, 0.25 ml TE buffer and
1 ml Platinum Taq (Invitrogen). Reactions were completed using
aP C Ra t9 5 8C for 10 min and 14 cycles at 958C for 15 s and at
608C for 4 min. The preampliﬁed cDNA was diluted 1:2 with TE
b u f f e ra n du s e df o rt h eB i o m a r k4 8 . 4 8d y n a m i ca r r a yc h i p( F l u i -
digm, San Francisco, CA, USA). Transcription levels were deter-
mined in triplicate reactions and normalized to the average of two
housekeeping genes (GAPDH and RPLPO) with the formula
2
2(DCt). For choosing the reference genes, four different house-
keeping genes were analyzed; CTNNB1, EEF1a, GAPDH and
RPLPO, from which the most stable reference genes (GAPDH
and RPLPO) were determined using the geNorm algorithm in
qBasePlus software (Biogazelle).
Meiotic spreads
Cells were collected and resuspended to 500 ml of hypoextrac-
tion buffer [30 mM Tris (Sigma-Aldrich), 50 mM sucrose
(Sigma-Aldrich), 17 mM citric acid (Sigma-Aldrich), 5 mM
EDTA (Invitrogen), two tablets of Complete Mini (Roche);
pH 8.2]. Solution was incubated for 30 min on ice and spun
down. The cell pellet was resuspended in 20 ml of hypoextrac-
tion buffer and 60 ml of 100 mM sucrose. Solution was dropped
on a slide that was dipped into 1% PFA and 0.15% Triton
X-100 and then incubated overnight at +48C. (Alternatively,
the cell suspension in hypoextraction buffer was cytospin at
180g for 3 min onto slides and ﬁxed in 4% PFA for 15 min.)
The slide was washed with PBS and incubated for 5 min
with 0.04% photoﬂo (KODAK) followed by blocking for
60 min with 4% goat serum in 1% BSA and 0.1% Tween-20
in PBS. Rabbit polyclonal anti-SCP3 primary antibody
(Novus Biologicals, Littleton, CO, USA) was used at 1:1000
dilution, and mouse polyclonal anti-CENP-A antibody was
used at 1:500 dilution and incubated for 3 h at room tempera-
ture. Slides were washed 3× with 1% BSA + 0.1%
Tween-20 in PBS, and goat anti-rabbit Alexa 594 and goat anti-
mouse Alexa 488 secondary antibodies (Invitrogen) were
applied at 1:1000 dilution and incubated for 1 h at room temp-
erature. Slides were washed three times and then ProLong Gold
antifade reagent with DAPI (Invitrogen) was applied.
Overexpression of DAZ gene family members
Undifferentiated cells were transduced on matrigel-coated
plates with lentiviral overexpression vectors for
DAZL, BOULE and in addition DAZ for XY cell lines (15)
supplemented with 8 mg/ml of polybrene (Sigma-Aldrich).
The transduction was done at 378C using one-third of DAZL
overexpression viral supernatant, one-third of BOULE super-
natant and one-third of DAZ supernatant or conditioned
medium. After 6 h, the conditioned medium was added and
cells were further incubated overnight. Virus supernatants
were washed off, and the conditioned medium was added
until the following day. Cells were then selected in the con-
ditioned medium with 2 mg/ml of blasticidin (Invitrogen) for
3 days, after which the differentiation was started with the
differentiation medium described above. The medium was
changed every 3–4 days.
DNA content staining for FACS analysis
Cells were collected as described above and ﬁxed with 70%
ethanol for 1 h at room temperature. Cells were then incubated
in a staining solution [0.1% Triton X-100, 0.2 mg/ml of RNase
A and 0.02 mg/ml of propidium iodide (Invitrogen)] for
15 min at +378C. The cell suspension was used for FACS.
Fluorescent in situ hybridization
Sorted cell populations were collected by cytospin at 180g for
3 min. Slides were ﬁxed with Carnoy’s ﬁxative (1:3 acetic
acid:methanol) for 5 min and air-dried. The slides were then
dehydrated in ice-cold 70, 80 and 100% ethanol, 2 min each
and air-dried. FISH probe against chromosome 16 (Vysis)
was denatured on slides at 858C and hybridized at 378C over-
night. Slides were then washed with 2× SSC and 0.1% SDS in
2× SSC at 508C, 5 min each. Prolong Gold anti-fade with
DAPI was applied to slides.
ACROSIN staining
Sorted cell populations from DNA content analysis were
cytospin as described above. The slides were ﬁxed with
4% paraformaldehyde for 15 min and then incubated with
1% Triton X-100 for 15 min, followed by washes with 0.1%
Tween-20. Slides were blocked with 4% goat serum for 1 h
at room temperature and stained with antibody against
ACROSIN (Santa Cruz) diluted 1:50 with 1% goat serum at
+48C overnight. Slides were washed and goat anti-rabbit
Alexa 488 (Invitrogen) secondary antibody was applied at
1:1000 for 1 h at room temperature, followed by washes and
mounting as described above.
Statistical analysis
The statistical analysis for gene expression results for
BMP-induced differentiation was performed with one-way
ANOVA, followed by the Bonferroni post-test. All four
cell lines were compared within each time group;
undifferentiated and 7 and 14 days differentiated cells for
each gene separately. Signiﬁcance was accepted at P , 0.05.
The statistical analysis for the gene expression of GFP-positive
and GFP-negative population was performed with an unpaired
t-test. Signiﬁcance was accepted at P , 0.05.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
ACKNOWLEDGEMENTS
We thank members of the Reijo Pera laboratory and the
Institute for Stem Cell Biology and Regenerative Medicine
for helpful discussions and technical assistance.
Conﬂict of Interest statement. None declared.
Human Molecular Genetics, 2011, Vol. 20, No. 4 761FUNDING
This work was supported by the California Institute of Regen-
erative Medicine (RL1-00670 and RC1-00137 to R.A.R.P.),
the Instituto de Salud Carlos III from the Spanish Ministry
of Science (FI07/00 011) and the National Institutes of
Health (R21HL089027 to J.C.W.). Funding to pay the Open
Access publication charges for this article was provided by
the California Institute for Regenerative Medicine.
REFERENCES
1. Okita, K., Ichisaka, T. and Yamanaka, S. (2007) Generation of
germline-competent induced pluripotent stem cells. Nature, 448,
313–318.
2. Yu, J., Vodyanik, M., Smuga-Otto, K., Antosiewicz-Bourget, J., France,
J., Tian, S., Nie, J., Jonsdottir, G., Ruotti, V., Stewart, R. et al. (2007)
Induced pluripotent stem cell lines derived from human somatic cells.
Science, 318, 1917–1920.
3. Woltjen, K., Michael, I., Mohseni, P., Desai, R., Mileikovsky, M.,
Ha ¨ma ¨la ¨inen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M. et al.
(2009) piggyBac transposition reprograms ﬁbroblasts to induced
pluripotent stem cells. Nature, 458, 766–770.
4. Park, T., Galic, Z., Conway, A., Lindgren, A., van Handel, B., Magnusson,
M., Richter, L., Teitell, M., Mikkola, H., Lowry, W. et al. (2009)
Derivation of primordial germ cells from human embryonic and induced
pluripotent stem cells is signiﬁcantly improved by coculture with human
fetal gonadal cells. Stem Cells, 27, 783–795.
5. Zou, J., Maeder, M., Mali, P., Pruett-Miller, S., Thibodeau-Beganny, S.,
Chou, B., Chen, G., Ye, Z., Park, I., Daley, G. et al. (2009) Gene targeting
of a disease-related gene in human induced pluripotent stem and
embryonic stem cells. Cell Stem Cell, 5, 97–110.
6. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T.,
Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N. and Yamanaka, S. (2008)
Generation of induced pluripotent stem cells without Myc from mouse and
human ﬁbroblasts. Nat. Biotechnol., 26, 101–106.
7. Takahashi, K., Okita, K., Nakagawa, M. and Yamanaka, S. (2007)
Induction of pluripotent stem cells from ﬁbroblast cultures. Nat. Protoc.,
2, 3081–3089.
8. Liu, H., Zhu, F., Yong, J., Zhang, P., Hou, P., Li, H., Jiang, W., Cai, J.,
Liu, M. and Cui, K. (2008) Generation of induced pluripotent stem cells
from adult rhesus monkey ﬁbroblasts. Cell Stem Cell, 3, 587–590.
9. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda,
K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult
human ﬁbroblasts by deﬁned factors. Cell, 131, 861–872.
10. Yamanaka, S. (2007) Strategies and new developments in the generation
of patient-speciﬁc pluripotent stem cells. Cell Stem Cell, 1, 39–49.
11. Yamanaka, S. (2008) Pluripotency and nuclear reprogramming. Philos.
Trans. R. Soc. Lond. B Biol. Sci., 363, 2079–2087.
12. Bucay, N., Yebra, M., Cirulli, V., Afrikanova, I., Kaido, T., Hayek, A. and
Montgomery, A. (2009) A novel approach for the derivation of putative
primordial germ cells and Sertoli cells from human embryonic stem cells.
Stem Cells, 27, 68–77.
13. Clark, A.T., Bodnar, M.S., Fox, M.S., Rodriquez, R.T., Abeyta, M.J.,
Firpo, M.T. and Reijo Pera, R.A. (2004) Spontaneous differentiation of
germ cells from human embryonic stem cells in vitro. Hum. Mol. Genet.,
13, 727–739.
14. Clark, A.T., Rodriguez, R., Bodnar, M., Abeyta, M., Turek, P., Firpo, M.
and Reijo Pera, R.A. (2004) Human STELLAR, NANOG, and GDF3
genes are expressed in pluripotent cells and map to chromosome 12p13, a
hot-spot for teratocarcinoma. Stem Cells, 22, 169–179.
15. Kee, K., Angeles, V., Flores, M., Nguyen, H. and Reijo Pera, R.A. (2009)
Human DAZL, DAZ and BOULE genes modulate primordial germ cell
and haploid gamete formation. Nature, 462, 222–225.
16. Kee, K., Gonsalves, J., Clark, A. and Reijo Pera, R.A. (2006) Bone
morphogenetic proteins induce germ cell differentiation from human
embryonic stem cells. Stem Cells Dev., 15, 831–837.
17. Tilgner, K., Atkinson, S., Golebiewska, A., Stojkovic, M., Lako, M. and
Armstrong, L. (2008) Isolation of primordial germ cells from
differentiating human embryonic stem cells. Stem Cells, 26, 3075–3085.
18. Chen, H., Kuo, H., Chien, C., Shun, C., Yao, Y., Ip, P., Chuang, C., Wang,
C., Yang, Y. and Ho, H. (2007) Derivation, characterization and
differentiation of human embryonic stem cells: comparing
serum-containing versus serum-free media and evidence of germ cell
differentiation. Hum. Reprod., 22, 567–577.
19. West, F., Machacek, D., Boyd, N., Pandiyan, K., Robbins, K. and Stice, S.
(2008) Enrichment and differentiation of human germ-like cells mediated
by feeder cells and basic ﬁbroblast growth factor signaling. Stem Cells, 26,
2768–2776.
20. Castrillon, D.H., Quade, B.J., Wang, T.Y., Quigley, C. and Crum, C.P.
(2000) The human VASA gene is speciﬁcally expressed in the germ cell
lineage. Proc. Natl Acad. Sci. USA, 97, 9585–9590.
21. Noce, T., Okamoto-Ito, S. and Tsunekawa, N. (2001) Vasa homology
genes in mammalian germ cell development. Cell Struct. Funct., 26,
131–136.
22. Hassold, T. and Hunt, P. (2001) To err (meiotically) is human: the genesis
of human aneuploidy. Nat. Rev. Genet., 2, 280–291.
23. Gonsalves, J., Sun, F., Schlegel, P.N., Turek, P.J., Hopps, C.V., Greene,
C., Martin, R.H. and Reijo Pera, R.A. (2004) Defective recombination in
infertile men. Hum. Mol. Genet., 13, 2875–2883.
24. Gonsalves, J., Turek, P., Schlegel, P., Hopps, C., Weier, J. and Reijo Pera,
R.A. (2005) Recombination in men with Klinefelter syndrome.
Reproduction, 130, 223–229.
25. Roig, I., Liebe, B., Egozcue, J., Cabero, L., Garcia, M. and Scherthan, H.
(2004) Female-speciﬁc features of recombinational double-stranded DNA
repair in relation to synapsis and telomere dynamics in human oocytes.
Chromosoma, 113, 22–33.
26. Reijo, R., Alagappan, R.K., Patrizio, P. and Page, D.C. (1996) Severe
oligospermia resulting from deletions of the Azoospermia Factor gene on
the Y chromosome. Lancet, 347, 1290–1293.
27. Reijo, R., Lee, T.Y., Salo, P., Alagappan, R., Brown, L.G., Rosenberg, M.,
Rozen, S., Jaffe, T., Straus, D., Hovatta, O. et al. (1995) Diverse
spermatogenic defects in humans caused by Y chromosome deletions
encompassing a novel RNA-binding protein gene. Nat. Genet., 10,
383–393.
28. Skaletsky, H., Kuroda-Kawaguchi, T., Minx, P.J., Cordum, H.S., Hillier,
L., Brown, L.G., Repping, S., Pyntikova, T., Ali, J., Bieri, T. et al. (2003)
The male-speciﬁc region of the human Y chromosome is a mosaic of
discrete sequence classes. Nature, 423, 825–837.
29. Vogt, P.H., Edelmann, A., Kirsch, S., Henegariu, O., Hirschmann, P.,
Kiesewetter, F., Kohn, F.M., Schill, W.B., Farah, S., Ramos, C. et al.
(1996) Human Y chromosome azoospermia factors (AZF) mapped to
different subregions in Yq11. Hum. Mol. Genet., 5, 933–943.
30. Davison, R.F. and M Conway, G.S. (2000) Mapping of the POF1 locus
and identiﬁcation of putative genes for premature ovarian failure. Mol.
Hum. Reprod., 6, 314–318.
31. Davison, R.M., Davis, C.J. and Conway, G.S. (1999) The X chromosome
and ovarian failure. Clin. Endocrinol., 51, 673–679.
32. Zinn, A.R., Page, D.C. and Fisher, E.M.C. (1993) Turner syndrome: the
case of the missing sex chromosome. Trends Genet., 9, 90–93.
33. Hendry, A.P., Wenburg, J.K., Bentzen, P., Volk, E.C. and Quinn, T.P.
(2000) Rapid evolution of reproductive isolation in the wild: evidence
from introduced salmon. Science, 290, 516–518.
34. Swanson, W.J. and Vacquier, V.D. (2002) The rapid evolution of
reproductive proteins. Nat. Rev., Genet., 3, 137–144.
35. Saitou, M., Barton, S.C. and Surani, M.A. (2002) A molecular programme
for the speciﬁcation of germ cell fate in mice. Nature, 418, 293–300.
36. Menken, J. and Larsen, U. (1994) Estimating the incidence and prevalence
and analyzing the correlates of infertility and sterility. Ann. N Y Acad. Sci.,
709, 249–265.
37. Hunt, P.A. and Hassold, T.J. (2002) Sex matters in meiosis. Science, 296,
2181–2183.
38. Hull, M.G.R., Glazener, C.M.A., Kelly, N.J., Conway, D.I., Foster, P.A.,
Hinton, R.A., Coulson, C., Lambert, P.A., Watt, E.M. and Desai, K.M.
(1985) Population study of causes, treatment, and outcome of infertility.
Br. Med. J., 291, 1693–1697.
39. Nicholas, C., Chavez, S., Baker, V. and Reijo Pera, R.A. (2009)
Instructing an embryonic stem cell-derived oocyte fate: lessons from
endogenous oogenesis. Endocr. Rev., 30, 264–283.
762 Human Molecular Genetics, 2011, Vol. 20, No. 4